Skip to main content

Published locations for Intravenous immunoglobulin controls dermatomyositis in phase 3 trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Intravenous immunoglobulin controls dermatomyositis in phase 3 trial

User login

  • Reset your password
  • /content/intravenous-immunoglobulin-controls-dermatomyositis-phase-3-trial
  • /edermatologynews/article/241011/lupus-connective-tissue-diseases/intravenous-immunoglobulin-controls
  • /familypracticenews/article/241011/lupus-connective-tissue-diseases/intravenous-immunoglobulin
  • /internalmedicinenews/article/241011/lupus-connective-tissue-diseases/intravenous-immunoglobulin
  • /rheumatologynews/article/241011/lupus-connective-tissue-diseases/intravenous-immunoglobulin-controls
  • /rheumatology/article/241011/lupus-connective-tissue-diseases/intravenous-immunoglobulin-controls
  • /internalmedicine/article/241011/lupus-connective-tissue-diseases/intravenous-immunoglobulin-controls
  • /dermatology/article/241011/lupus-connective-tissue-diseases/intravenous-immunoglobulin-controls
  • /familymedicine/article/241011/lupus-connective-tissue-diseases/intravenous-immunoglobulin-controls